The Precision Health Initiative is conducted by Genuity Science. Listen to our new podcast here.

Precision Health Initiative
Data Controller

Genuity Science (Ireland) Limited is responsible for the management and control of all EU Research Data in the Precision Health Initiative.
We are deeply committed to the ethical and responsible stewardship and use of all Research Data in a safe and secure manner in compliance with all applicable laws, including GDPR and the Irish Health Research Regulations.

Board of Directors

David Kavanagh, PhD,
Board Director

VP Clinical Operations,
Genuity Science
Managing Director,
Genuity Science (Ireland) Ltd.

“Genomics is the key to unlocking the potential of precision medicine.”

David leads Genuity Science’s global clinical operations and programmes and is the managing director of our Ireland site. David is primarily responsible for the establishment and management of long-term research partnerships with world leading health systems, biobanks and cohort research groups. The work of David and his team supports the ethical and responsible sourcing of human biological samples and deep phenotype data, the downstream project management of related genomic analysis projects and the support of the ongoing needs of our academic and healthcare partners. The team’s efforts ensure that our research teams have access to the highest quality data in order to deliver breakthrough insights to our pharma and biotech customers.
David has extensive experience in life sciences and has held leadership roles in several high-growth academic and commercial life science organisations including Systems Biology Ireland, located at University College Dublin and CompareNetworks, a San Francisco-based life science marketing company.  David’s areas of specialty include life science innovation and commercialisation, operational & high performing team development in life science start-up environments, genomics, systems biology, connected health, life science text mining and healthcare consulting.
David holds a PhD in Biochemistry from University College Dublin.

Paul Saunders, PhD,
Board Director

Senior Investment Director – Innovation, Ireland Strategic Investment Fund

Paul is Head of Innovation and Special Investments for the Ireland Strategic Investment Fund. Paul heads the fund’s investment agenda targeting large, transformative ‘Big Idea’ opportunities.
Prior to joining the Fund, Paul worked as Head of Innovation for the state-owned provider of postal services in the Republic of Ireland, An Post, working on initiatives in diverse areas including digital, payments, logistics, telecoms and retail. Paul has also worked as Group Development Director for Greencore, Bioenergy Development Director for NTR, and as Senior Consultant with McKinsey and Co., in Dublin and London. Paul started his career with Shell International in the Netherlands in various roles in geophysics, operations management, project economics and asset development.
Paul has a BSc in Physics from Bristol University, a PhD in Earthquake Physics from Cambridge University and an MBA from Insead.